Radiology
Radiology
Audio Summaries
Every issue of Radiology moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Recent summaries
The latest articles summarized from Radiology.
Quantitative CT Phenotypes and Prognosis in Combined Pulmonary Fibrosis and Emphysema.
Nov 17, 2026
Using AI-based quantitative CT on 1583 patients with combined pulmonary fibrosis and emphysema (CPFE), the authors asked whether patients could be objectively classified as fibrosis-dominant or emphysema-dominant based on which component occupied a greater percentage of the lungs. Fibrosis-dominant patients (52% of the cohort) had significantly higher all-cause mortality over a median follow-up of 2.59 years (adjusted hazard ratio 1.36), indicating that quantitative CT can identify CPFE phenotypes with distinct prognoses.
Endovascular Treatment versus Medical Management for Acute Anterior Circulation Large Vessel Occlusion from 24 to 96 Hours.
Nov 17, 2026
This retrospective cohort study of 308 Chinese patients with large vessel occlusion stroke presenting 24 to 96 hours after symptom onset asked whether endovascular treatment (EVT) improves outcomes compared with best medical management alone. EVT was associated with substantially higher 90-day functional independence (50.7% vs 28.2%; adjusted OR 3.8), with no significant difference in symptomatic intracranial hemorrhage or 90-day mortality. Because the design is observational, these findings are hypothesis-generating and do not establish causation, though they suggest a potential benefit of EVT in this extended time window.
Histotripsy versus Established Thermal Ablation Technologies: A Comparative Analysis of FDA MAUDE Adverse Event Reporting Patterns.
Nov 17, 2026
This study compared adverse event reports in the FDA MAUDE database for histotripsy, a newly cleared liver tumor ablation technology, against pooled microwave and radiofrequency ablation reports over comparable early postmarket periods. The authors asked whether histotripsy shows a higher reported frequency of serious injury and death. They found histotripsy had substantially higher reporting odds of serious injury and death than pooled MWA/RFA, though the authors caution that differences in technology maturity and reporting era may explain part of this gap and that prospective study is needed.
Temporal Trends in High-Risk Benign Breast Disease Detection at Screening Mammography: Results from the Breast Cancer Surveillance Consortium.
Nov 17, 2026
This BCSC cohort study of 4.47 million screening mammograms (2005–2022) examined how detection rates of high-risk benign breast disease (BBD) changed over time and whether digital breast tomosynthesis (DBT) detects more of these lesions than digital mammography. Overall high-risk BBD detection showed no significant trend since 2017, with atypical ductal hyperplasia declining from 2009 to 2017 while radial sclerosing and atypical papillary lesions rose. DBT was associated with higher odds of detecting high-risk BBD overall (OR 1.36), including lobular carcinoma in situ, atypical lobular hyperplasia, and radial sclerosing lesions.
Gadolinium Retention in Pediatric Bone: Linear versus Macrocyclic MRI Contrast Agents.
Nov 10, 2026
This prospective pilot study quantified gadolinium concentrations in bone tissue from 29 children undergoing sternotomy, comparing those exposed to the linear agent gadobenate, the macrocyclic agent gadoterate, and unexposed controls. The authors asked whether linear and macrocyclic GBCA exposure leave different amounts of residual gadolinium in pediatric bone. Gadobenate exposure was associated with substantially higher bone gadolinium (median 0.141 μg/g) than gadoterate (0.007 μg/g) or no exposure (0.001 μg/g), suggesting linear agents cause greater retention in children.
Low-Dose CT Lung-RADS 2022 for the Management of Screening- and Non-Screening-detected Lung Cancer Associated with Cystic Airspaces.
Nov 10, 2026
This secondary analysis of 1,258 participants from the NLST, ITALUNG, and LUSI trials examined whether lung cancers associated with cystic airspaces (CA) differ in outcomes from noncystic non-small cell lung cancer and whether Lung-RADS 2022 could enable earlier diagnosis. Seventy-three CA-associated cancers (about 6% of both screening- and non-screening-detected cancers) showed 5-year lung cancer-specific survival of 51.4%, similar to the 53.2% for noncystic NSCLC (subdistribution hazard ratio 1.15, P = .44). The authors found that Lung-RADS 2022 criteria for atypical cysts might have allowed earlier diagnosis in 75% of these cancers.
Comparison of 7-T and 3-T MRI for the Detection of Multiple Sclerosis Lesions.
Nov 10, 2026
This study compared 7-T and 3-T MRI in 30 patients with multiple sclerosis to determine whether 7-T improves lesion detection across brain regions and key biomarkers, including the central vein sign (CVS) and paramagnetic rim lesions (PRLs). Seven-tesla MRI detected 27.5% more lesions overall (2268 vs 1779), with the largest gains in cortical lesions, and identified far more CVS-positive lesions (1451 vs 592), while PRL proportions were similar between the two field strengths. The findings support 7-T MRI's added value for MS lesion detection, particularly for CVS assessment.
Glandular Tissue Component at Preoperative Breast US and Recurrence Risk in Invasive Breast Cancer.
Nov 10, 2026
High glandular tissue component (GTC) on preoperative breast ultrasound was independently associated with roughly double the risk of ipsilateral or contralateral breast cancer after invasive breast cancer treatment, consistently across a Korean and a Chinese cohort totaling about 8,900 women. The study asked whether GTC predicts recurrence in invasive breast cancer, and found no association with regional or distant recurrence at either site. These findings suggest that GTC on routine breast US may help identify patients at higher risk of new breast cancers rather than of systemic or locoregional spread.
Predicting Lymph Node Metastasis in Part-Solid Lung Adenocarcinomas with a Maximum Solid Portion Diameter of 30.0 mm.
Nov 3, 2026
This retrospective study of 1444 patients with part-solid lung adenocarcinomas (solid portion ≤30.0 mm) asked which CT features best predict lymph node metastasis, which occurred in 4.7% of patients. Solid portion diameter was the only independent predictor and outperformed consolidation-to-tumor ratio (AUC 0.86 vs 0.75), with a clinically actionable cutoff of 7.3 mm (sensitivity 95.6%, specificity 49.6%). No patients with a CTR of 0.25 or less had nodal metastasis, suggesting solid portion diameter may better guide intraoperative lymph node evaluation.
Phase 2 Trial of 89Zr-Deferoxamine-Daratumumab for CD38-targeted Immuno-PET/CT Detection of Multiple Myeloma.
Nov 3, 2026
This phase 2 trial asked whether CD38-targeted 89Zr-DFO-daratumumab immuno-PET/CT could detect multiple myeloma better than standard 18F-FDG PET/CT in 60 participants. Overall detection rates were similar (43% for the immuno-PET versus 47% for FDG PET/CT, P = .81), but the immuno-PET alone identified active myeloma in 13% (8 of 60) of participants, which was confirmed on biopsy in those cases. The findings suggest that CD38-targeted immuno-PET can reveal disease missed by FDG PET/CT in some patients.
